The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2009

Filed:

Sep. 30, 2005
Applicants:

Takao Suzuki, Tsukuba, JP;

Minoru Moriya, Tsukuba, JP;

Shunji Sakuraba, Tsukuba, JP;

Sayaka Mizutani, Tsuchiura, JP;

Hisashi Iwaasa, Tsukuba, JP;

Akio Kanatani, Ushiku, JP;

Inventors:

Takao Suzuki, Tsukuba, JP;

Minoru Moriya, Tsukuba, JP;

Shunji Sakuraba, Tsukuba, JP;

Sayaka Mizutani, Tsuchiura, JP;

Hisashi Iwaasa, Tsukuba, JP;

Akio Kanatani, Ushiku, JP;

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 235/12 (2006.01); C07D 209/12 (2006.01); C07D 211/06 (2006.01); C07D 401/12 (2006.01); C07D 291/04 (2006.01); C07D 291/06 (2006.01); C07D 279/02 (2006.01); C07D 279/06 (2006.01); C07D 279/12 (2006.01); C07D 265/02 (2006.01); C07D 265/06 (2006.01); C07D 265/30 (2006.01); C07D 257/04 (2006.01); C07D 257/08 (2006.01); C07D 251/04 (2006.01); C07D 237/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

A compound represented by the formula [I]: [wherein Rand Rare the same or different and each represents Calkyl, Ccycloalkyl, et al; R, R, and Rare the same or different and each represents hydrogen, Calkyl, et al; X represents —N—, —CH—, et al; Yrepresents a single bond, Calkylene, et al; Yrepresents Calkylene, oxy(Calkylene), et al; Arrepresents a monocyclic aromatic carbocyclic group, monocyclic aromatic heterocyclic group, et al; and Arrepresents a 5- or 6-membered aromatic carbocyclic group, aromatic heterocyclic group, et al]. This compound functions as a melanin-concentrating hormone receptor antagonist and is useful as, e.g., a therapeutic agent for obesity, et al.


Find Patent Forward Citations

Loading…